Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2010
06/30/2010CN101762473A Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method
06/30/2010CN101762472A Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method
06/30/2010CN101762471A Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method
06/30/2010CN101762470A Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method
06/30/2010CN101762469A Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method
06/30/2010CN101762468A Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method
06/30/2010CN101762467A Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method
06/30/2010CN101762466A Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method
06/30/2010CN101762465A Homocysteine diagnosis/determination reagent (kit) and homocysteine concentration determination method
06/30/2010CN101762418A Paper sheet stiffness tester
06/30/2010CN101762345A Working condition detection system for crawler walking hydraulic bracket
06/30/2010CN101760557A Reagent kit for auxiliary diagnosis of hepatoma
06/30/2010CN101760508A Identification method research of wheat-secale cereale L 1BL/1RS translocation line
06/30/2010CN101760467A Construction method of recombinant T4 bacteriophage for expressing Newcastle disease virus NP gene and application thereof
06/30/2010CN101760428A Microfluidic chip for enriching microorganisms in air and preparation method thereof
06/30/2010CN101759804A Anti-human thyroglobulin monoclonal antibody and application thereof
06/30/2010CN101759800A Preparation of dirhamnolipid artificial antigen and antibody, enzyme-linked immunity test paper, preparation and detection method thereof
06/30/2010CN101759799A Method for preparing immunogen chloramphenicol
06/30/2010CN101759797A Phycocyanin beta subunits fluorescent protein combined with phycoerythrobilin PEB and application thereof
06/30/2010CN101759796A Allophycocyanin subunits fluorescent protein combined with phycocyanobilin PCB and application thereof
06/30/2010CN101759795A Molecular design phycoerythrocyanin beta subunit fluorescent protein combining phycocyanobilin (PCB) and application thereof
06/30/2010CN101759794A Molecular design phycoerythrocyanin beta subunit fluorescent protein combining phycoerythrobilin and application thereof
06/30/2010CN101759793A Phycocyanin and phycoerythrin alpha subunits fluorescent protein combined with phycoerythrobilin PEB and application thereof
06/30/2010CN101759792A Phycocyanin and phycoerythrin beta subunits fluorescent protein combined with phycocyanobilin PCB and application thereof
06/30/2010CN101759791A Phycocyanin and phycoerythrin beta subunits fluorescent protein combined with phycoerythrobilin PEB and application thereof
06/30/2010CN101759790A Allophycocyanin subunits fluorescent protein combined with phycoerythrobilin PEB and application thereof
06/30/2010CN101759789A Phycocyanin beta subunits fluorescent protein combined with phycocyanobilin PCB and application thereof
06/30/2010CN101759788A Molecular design phycocyanin beta subunit fluorescent protein combining phycocyanobilin and application thereof
06/30/2010CN101759787A Molecular design phycocyanin beta subunit fluorescent protein combining phycoerythrobilin and application thereof
06/30/2010CN101759786A Phycocyanin alpha subunits fluorescent protein combined with phycocyanobilin PCB and application thereof
06/30/2010CN101759785A Phycocyanin alpha subunits fluorescent protein combined with phycoerythrobilin PEB and application thereof
06/30/2010CN101759780A Soluble liver antigen T cell epitope and detection kit prepared thereof
06/30/2010CN101759701A Preparation method of novel porphyrin
06/30/2010CN101759142A Preparation method of nanoliquid test device
06/30/2010CN101756789A Preferential three-step method of production process for diclofenac sodium mucilage
06/30/2010CN101228837B Method of regulating apple seedling-plant transition stage
06/30/2010CN101216404B Air pressure temperature control type landfill pollutant transfer characteristic test system
06/30/2010CN101210044B Polypeptide and application thereof
06/30/2010CN101187609B Piezo-electric drive type micro mixing chip
06/30/2010CN101140271B Galvanizing plate layered detecting method
06/30/2010CN101118231B Method for measuring paint film odor relative light and heavy degree and device thereof
06/30/2010CN101000336B Dynamic investigating method for performance of reverse osmosis antisludging agent
06/29/2010US7747394 Information processing system using base sequence relevant information
06/29/2010US7747393 Methods, systems, and software for identifying functional biomolecules
06/29/2010US7747392 Physiogenomic method for predicting clinical outcomes of treatments in patients
06/29/2010US7747391 Methods, systems, and software for identifying functional biomolecules
06/29/2010US7747390 Digital cell
06/29/2010US7747389 Database profile of hepatocellular carcinoma gene seqences for use as predictive elements for recurring cell proliferative disorders; tumor diagnosis
06/29/2010US7747049 Method of analysing a representation of a separation pattern
06/29/2010US7747048 Method of analysing separation patterns
06/29/2010US7745691 Genetically modified mouse lacking diacylglycerol acyltransferase-1 (DGAT-1) activity
06/29/2010US7745690 animal models whose genome comprises a foreign DNA, comprising a type II collagen promoter, a major histocompatibility complex class II transactivator gene and a type II collagen enhancer sequence; elucidation of the onset mechanism of rheumatic diseases and for drug screening or design
06/29/2010US7745689 Nephropathy-associated gene
06/29/2010US7745688 Model mouse of Alzheimer's disease expressing FAD APP 716 and use thereof
06/29/2010US7745611 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA
06/29/2010US7745604 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell
06/29/2010US7745600 a polynucleotide comprising a nucleotide sequence that codes for a sodium channel protein having an amino acid sequence in which one or more amino acids differs from the amino acids in the wild-type protein by replacements, used for screening compounds for use as antiarrhythmic agents
06/29/2010US7745586 antiidiotypic, chimeric, humanized, monoclonal or polyclonal antibodies or faragments that specifically binds polypeptides having synthetase enzyme activity
06/29/2010US7745582 Purification of immunoglobulins from solution (hybridoma cell culture supernatants, animal plasma or sera, or colostrum); solid phase synthesis
06/29/2010US7745581 T-bet compositions and methods of use thereof
06/29/2010US7745569 polypeptide comprising amino acid sequences that interact with amyloid plaques containing amyloid beta (A beta ) peptide, useful as carrier molecules to deliver drugs and diagnostic reagents to amyloid plaques
06/29/2010US7745485 Inhibiting metastasis of cancer cells by administering a phosphatidyl inositol 3-kinase inhibitor such as Wortmannin or LY294002 (2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one)
06/29/2010US7745413 Collection of traceable compounds and uses thereof
06/29/2010US7745389 Factor H gene polymorphisms and haplotypes; complement inhibitors
06/29/2010US7745388 Peptide for use in the treatment of cell damage caused by ischemia
06/29/2010US7745377 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation
06/29/2010US7745230 Estrogen receptors and methods of use
06/29/2010US7745229 Chemoselective fluorgenic molecular linkers and methods for their preparation and use
06/29/2010US7745228 detectors comprising a membrane with an application zone for applying liquid samples,indicator zones, which interact with the analytes and an absorption region, used for qualitative or quantitative analysis of analytes
06/29/2010US7745227 System for analysis of explosives
06/29/2010US7745225 determining extracellular matrix protein of the dermal tissue, obtaining fibroblasts derived from the dermal tissue, determining potential of fibroblasts to synthesize an extracellular matrix protein, determining the DNA content of the fibroblasts, assessing kinetics of fibroblast outgrowth
06/29/2010US7745224 Procedure for the standardization of coagulation tests
06/29/2010US7745223 surface treatment of plastics by exposing it to ionized atoms or molecules, to increase the adhesion strength of coagulated blood on the surface by increasing the surface interaction of blood components like fibrin, fibrinogen and thrombocytes; used in blood diagnostics such as hemostasis analysis
06/29/2010US7745222 Amyloid binding assays
06/29/2010US7745221 fluorescence activated cell sorter based on switches that illuminate portions of the flow path for rapid, active control of cell routing through the passageways
06/29/2010US7745219 Reagent composition for the analysis of residual white blood cells in leuko-reduced blood banking products
06/29/2010US7745216 Methods and reagents for treating glucose metabolic disorders
06/29/2010US7745213 nucleotide sequences coding potassium chanel protein for use in identifying modulator for prevention and treatment of cardiovascular/myocardial disorders; utilized to diagnose and screen for short QT syndrome, long QT syndrome, Brugada syndrome and progressive conduction disease
06/29/2010US7745212 Melanoma antigens and their use in diagnostic and therapeutic methods
06/29/2010US7745203 Biochip comprising immobilized nucleic acid for use in identifying single nucleotide polymorphism; characterization of allelic mutation in preferential gene sequences
06/29/2010US7745196 a cell containing a recombinant nucleic acid encoding a polypeptide modified for intracellular presentation; library of cells; using polypeptides to treat receptor-related condition
06/29/2010US7745193 recombinant nucleotide sequence which codes upon expression for at least a part of a bifunctional hybrid active-site serine beta -lactamase protein
06/29/2010US7745178 Complexity management of genomic DNA
06/29/2010US7745165 Calibration of colorectal cancer; gene expression profile; administering to human an antibody which binds to protein markers
06/29/2010US7745163 contacting sample with a reagent comprising a thiol-containing compound, a halo-acetyl-CoA or a halo-acetyl-pantetheine, and an acetyltransferase under conditions suitable for acetyltransferase enzyme activity then identifying a substrate that has formed a base-stable covalent bond to the reagent
06/29/2010US7745162 Compositions and methods for measuring levels of bioactive human hepcidin
06/29/2010US7745161 Using heat variation in a mixture to monitor increases in intensity of enzymatic reactions; screening/ligand membrane protein interactions
06/29/2010US7745160 Method of amplifying ATP and use thereof
06/29/2010US7745159 Using presence and concentration of mesothelin related antigen (MRA) to detect and prognose tumors; antitumor agents
06/29/2010US7745158 Detection of secreted aspartyl proteases from Candida species
06/29/2010US7745157 Enhancing an immune response to an antigen in a mammal by administering lymphocyte conditioned median based on a mixture of cytokines and chemokines obtained from peripheral blood mononuclear cells stimulated with antiCD3/CD28-coated beads; used with traditional vaccines or cancer immunotherapy
06/29/2010US7745156 Methods for diagnosis and treatment of epithelial-derived cancers
06/29/2010US7745155 In-vivo monitoring of circulating apoptotic cells
06/29/2010US7745154 Preventives/remedies for myeloma tumor and method of diagnosing the same
06/29/2010US7745153 comprising pyrocatechol violet, sodium molybdate, polyvinyl alcohol, methanol, succinic acid, sodium oxalate, sodium benzoate and polyvinyl pyrrolidone
06/29/2010US7745152 Method for determining genotoxicity
06/29/2010US7745151 Methods of determining binding between Nogo receptor and p75 neurotrophin receptor
06/29/2010US7745150 Methods for the detection and monitoring of congestive heart failure
06/29/2010US7745149 Tumor markers for ovarian cancer diagnosis
06/29/2010US7745148 enhancing the specific productivity ratio of antibody expression of a mammalian cell line which expresses an antibody of interest using knock out techniques; inserting expression promoters rather than anti-sense RNA or other expression suppression constructs
1 ... 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 ... 3937